CRYBG3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.426800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.134000E-01
Normal-vs-Stage2
9.386200E-01
Normal-vs-Stage3
9.401900E-02
Normal-vs-Stage4
3.307000E-01
Stage1-vs-Stage2
7.813400E-01
Stage1-vs-Stage3
6.663600E-02
Stage1-vs-Stage4
4.535400E-01
Stage2-vs-Stage3
1.983300E-04
Stage2-vs-Stage4
2.580400E-01
Stage3-vs-Stage4
9.864000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.097400E-01
Normal-vs-AfricanAmerican
6.849800E-01
Normal-vs-Asian
7.578200E-01
Caucasian-vs-AfricanAmerican
3.567400E-01
Caucasian-vs-Asian
7.182600E-01
AfricanAmerican-vs-Asian
3.376600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.475800E-01
Normal-vs-Female
9.485600E-01
Male-vs-Female
9.913400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.020800E-01
Normal-vs-Age(41-60Yrs)
7.095600E-01
Normal-vs-Age(61-80Yrs)
8.250800E-01
Normal-vs-Age(81-100Yrs)
2.728400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.061400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.586200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.795600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.995900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.719870E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.191570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.775400E-01
Normal-vs-Daily Drinker
3.631400E-01
Normal-vs-Weekly Drinker
8.051400E-01
Normal-vs-Occasional Drinker
6.638800E-01
Normal-vs-Social Drinker
7.574400E-01
Non Drinker-vs-Daily Drinker
2.672600E-01
Non Drinker-vs-Weekly Drinker
7.406000E-01
Non Drinker-vs-Occasional Drinker
8.831200E-01
Non Drinker-vs-Social Drinker
2.579000E-01
Daily Drinker-vs-Weekly Drinker
2.126000E-01
Daily Drinker-vs-Occasional Drinker
4.212400E-01
Daily Drinker-vs-Social Drinker
9.801900E-02
Weekly Drinker-vs-Occasional Drinker
6.818200E-01
Weekly Drinker-vs-Social Drinker
3.673200E-01
Occasional Drinker-vs-Social Drinker
2.488000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.401600E-01
Normal-vs-Grade 2
3.516200E-02
Normal-vs-Grade 3
2.087800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.781200E-03
Grade 1-vs-Grade 3
4.382300E-02
Grade 1-vs-Grade 4
3.401600E-01
Grade 2-vs-Grade 3
4.464200E-01
Grade 2-vs-Grade 4
3.516200E-02
Grade 3-vs-Grade 4
2.087800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.650200E-01
Normal-vs-NonDiabetic
8.084000E-01
Diabetic-vs-NonDiabetic
9.167400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.547600E-01
Normal-vs-NoPancreatitis
8.303200E-01
Pancreatitis-vs-NoPancreatitis
9.081600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.327400E-01
Normal-vs-N1
9.230400E-01
N0-vs-N1
1.090400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.530200E-01
Normal-vs-TP53-NonMutant
7.559200E-01
TP53-Mutant-vs-TP53-NonMutant
5.029200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
